Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.980 | 1.980 | 0.000 |
Shares | 98.020 | 98.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.851 | 16.342 |
Price to Book | 4.993 | 2.722 |
Price to Sales | 3.522 | 2.092 |
Price to Cash Flow | 18.784 | 10.483 |
Dividend Yield | 1.422 | 2.778 |
5 Years Earnings Growth | 10.908 | 13.012 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 29.930 | 12.883 |
Technology | 21.360 | 20.011 |
Industrials | 20.380 | 13.902 |
Consumer Cyclical | 13.060 | 12.526 |
Basic Materials | 7.760 | 9.101 |
Consumer Defensive | 7.510 | 8.423 |
Number of long holdings: 40
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.13 | 622.6 | +5.67% | |
ASML Holding | NL0010273215 | 6.75 | 688.50 | +0.69% | |
EssilorLuxottica | FR0000121667 | 5.13 | 231.90 | -0.09% | |
Schneider Electric | FR0000121972 | 4.93 | 239.80 | +0.29% | |
Alcon | CH0432492467 | 4.26 | 76.46 | +0.58% | |
Air Liquide | FR0000120073 | 4.03 | 154.34 | +0.06% | |
Relx | GB00B2B0DG97 | 3.68 | 3,617.00 | +0.25% | |
Experian | GB00B19NLV48 | 3.66 | 3,464.0 | -0.03% | |
Inditex | ES0148396007 | 3.26 | 49.510 | +0.14% | |
Dassault Systemes | FR0014003TT8 | 3.21 | 33.45 | +1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World USD Acc | 938.51M | 10.95 | 2.87 | 8.65 | ||
Emerging Markets USD Acc | 436.88M | -1.47 | -5.65 | -1.45 | ||
Emerging Markets USD Dis | 436.88M | -1.46 | -5.64 | -1.44 | ||
Asia USD Acc | 159.87M | 3.60 | -8.14 | 4.12 | ||
India USD Acc | 96.61M | 14.98 | 8.79 | 7.24 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review